Pharmaniaga Berhad Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
Pharmaniaga Berhad Stock Forecast and Price Target
Given the average yearlong price target of RM0.31 provided by prominent analysts over the past few months, there is a potential downside of approximately -8.82% from the last closing price in April, 2024 for Pharmaniaga Berhad's stock if it is reached. This estimation is based on a high estimate of RM0.31 and a low estimate of RM0.31.
-8.82% Downside
Pharmaniaga Berhad Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Pharmaniaga Berhad's Price has decreased from RM0.03 to RM0.00 – a 100.00% drop! In the next year, analysts expect Fair Value to reach RM0.36 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
Pharmaniaga Berhad Revenue Forecast for 2023 - 2025 - 2030
Pharmaniaga Berhad's Revenue has increased by 24.93% In the last three years, going from RM2.73B to RM3.40B. The next year, 1 experts forecast that Pharmaniaga Berhad's Revenue will decrease by 17.17%, reaching RM2.82B. In 2030, professionals predict that Pharmaniaga Berhad's Revenue will decrease by 1.20%, reaching RM3.36B.
.jpg)
Pharmaniaga Berhad Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Pharmaniaga Berhad has seen a decline in its Dividend per Share, from RM0.02 to RM0.02 – a 0.00% decrease. According to the 1 analysts polled, in the next year, Pharmaniaga Berhad's Dividend per Share will fall by 100.00%, reaching RM0.00. By 2030, professionals believe that Pharmaniaga Berhad's Dividend per Share will have decreased by 100.00%, falling to RM0.00.
Pharmaniaga Berhad EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Pharmaniaga Berhad's EBITDA has fallen from RM94.43M to RM29.56M – a 68.70% decrease. Next year, analysts are expecting EBITDA to reach RM144.40M – an increase of 388.50%. Over the next seven years, the forecast is for EBITDA to grow by 6374.01%.
Pharmaniaga Berhad EBIT Forecast for 2023 - 2025 - 2030
Pharmaniaga Berhad's EBIT has decreased In the last three years, from RM67.59M to RM-5.11M – a 107.56% drop. In the following year, 1 experts forecast Pharmaniaga Berhad's EBIT will decrease by 2327.01%, to RM113.80M. In 2030, professionals predict that Pharmaniaga Berhad's EBIT will decrease by 2987147204.20%, to RM152.64T.
Pharmaniaga Berhad EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Pharmaniaga Berhad's EPS has decreased from RM0.02 to RM0.00 – a 100.00% drop! In the next year, analysts expect EPS to reach RM0.03 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)